Treatment is out-patient at the Clinic. Additional follow-up both and home and visiting the clinic may be required. Best results are in renal cancer, but they treat most cancers. They use specific and non-specific transfer factor; low dose IL-2 injected intralymphatically, interferon, LAK cells (lymphokine activated killer cells), interferon-alpha, and hormone therapy. Currently they have a proposed research study on transfer factor as a form of immunotherapy for advanced metastatic prostate cancer stage D3.